Abstract
AbstractDespite its 100% lethality and approximately 59,000 human deaths a year, rabies is still in want of an effective treatment. A host of trials has been described aiming at impairing the life cycle ofLyssavirus rabies(RABV), the chief worldwide lyssavirus causing rabies, but with limited success. In this study, mice intranasally inoculated with the CVS strain of RABV were serially treated with 50µg/day of the Poly ICLC Hiltonol® jn MEM showed significantly higher survival time and disease incubation period as compared to control mice that received MEM only. These very preliminary results indicate that Hiltonol® might be an effective drug against rabies that merits widerin vivoinvestigation.
Publisher
Cold Spring Harbor Laboratory
Reference14 articles.
1. Antiviral therapy for human rabies
2. An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine;Bull World Health Organ,1979
3. Dean DJ , Abelseth MK , Atanasiu P. The fluorescent antibody test In: Koprovsky H. The laboratory techniques in rabies. Geneva. 1996. 476p.
4. Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses
5. Therapy of Murine Rabies after Exposure: Efficacy of Polyriboinosinic-PolYribocytidylic Acid Alone and in Combination with Three Rabies Vaccines